Ledger.Open graph →
SEC Form D · Amendment · filed May 21, 2014

Atea Pharmaceuticals, Inc

Offering
$20.0M
Sold
$14.7M
Exemption
Rule 506(b)
Industry
Other
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Vanessa Otero · Westminster, COExec · DirectorMadhavi N. Jain · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗